Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $22 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Jason M. Gerberry raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $22.00 (from $19.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
